Robier Aguillon-Prada's research works | University of Miami Miller School of Medicine, Florida (UM) and other places
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.,Journal of the American College of Cardiology - X-MOL
Robier Aguillon-Prada's research works | University of Miami Miller School of Medicine, Florida (UM) and other places
Robier Facebook, Twitter & MySpace on PeekYou
Dr. Robier Aguillon Prada, MD | Cleveland, OH | Healthgrades
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis | Science Translational Medicine
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study) - Sheng - 2020 - Clinical
FGF23 induces left ventricular hypertrophy
Cyclodextrin Protects Podocytes in Diabetic Kidney Disease | Diabetes
Dr. Robier Aguillon Prada, MD | Cleveland, OH | Healthgrades
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis | Science Translational Medicine
Supplementary Materials | Science Translational Medicine
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study) - Sheng - 2020 - Clinical
Dr. Robier Aguillon Prada, MD, Critical Care Medicine Specialist - Cleveland, OH | Sharecare
Table 1 from FGF23 induces left ventricular hypertrophy. | Semantic Scholar
Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk,Journal of the American College of Cardiology - X-MOL
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study) - Sheng - 2020 - Clinical
Robier Aguillon-Prada's research works | University of Miami Miller School of Medicine, Florida (UM) and other places